E.g., 07/24/2024
E.g., 07/24/2024
Titlesort descending Program description Type Credit Event date
Pharmacy Grand Rounds Episode 26: No Gout About It: Updates in the Management of Gout

Available until December 31, 2024 - Podcast.

Madison Fazio, Pharm.D. (@madison_fazio) discusses new guideline recommendations for the management of gout, reviews the literature contributing to the new gout recommendations, and recognizes patients that would benefit from newer gout therapies based on guideline recommendations

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 121: “Seeing R.E.D” Racial and Ethnic Disparities in Cardiovascular Disease State Medication

Available until December 31, 2024 - Pharmacy Podcast

Aleesha Jantzen, PharmD describes social determinants of health that impact management of cardiovascular disease states, recognizes racial/ethnic disparities in management of atrial fibrillation, myocardial infection, hypertension, and heart failure and identifies pharmacist interventions to minimize racial/ethnic disparities in cardiovascular disease state management.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 128: It’s Going Tibia Okay: Supportive Bone Health in Oncology

Available until December 31, 2024 - Pharmacy Podcast Online CME

Christopher R. Cahoon, PharmD defines the importance of optimizing bone health in patients with bone metastases and lytic lesions, describes preferred bone-targeted therapy for patients with malignancy-associated bone disease and discusses the safety limitations associated with bisphosphonates and RANKL inhibitors.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 129: Pharmacologic Treatment of Drug Resistant Hypercholesterolemia

Available until September 1, 2024 - Podcast Online CME Education

Seth M. Kriha, PharmD identifies guideline recommended treatment to reduce LDL-C, evaluates landmark clinical trials for novel therapeutic agents indicated for treatment resistant hypercholesterolemia and develops a pharmacologic care plan for a patient with treatment resistant hypercholesterolemia.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 130 : Clostridioides difficile Infection: Do We C the Diff-erence in Preventing Recurrence?

Available until September 1, 2024 - Podcast Online CME Education

Andrew (Andy) F. Wiener, PharmD describes the pathogenesis and risk factors of C. diff infection and recurrence, reviews the preferred treatment modalities for prevention of C. diff recurrence and describes the cost-benefit analysis supporting guideline-directed management of C. diff infections.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 131 : Off the Chain: The Drug Supply Chain and Medication Shortages

Available until September 1, 2024 - Podcast Online CME Education

Jo Ann Leal, PharmD describes the key components of the drug supply chain and the impact of drug shortages, identifies common organizational strategies used to mitigate drug shortages and evaluates recent national efforts to stabilize the drug supply chain.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 132 : Pharmacotherapy for the Treatment of Obesity

Available until September 1, 2024 - Podcast Online CME Education

Kristina M. Thurber, PharmD, BCPS recognizes pharmacotherapy for the treatment of obesity and explain mechanisms of action for each class, discusses and compares clinical data and weight loss outcomes for common treatment options, and determines an optimal pharmacologic regimen for the treatment of obesity given patient-specific factors.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 133 : Emerging Antibiotics – Tetra(cycle)ine Back to Basics

Available until September 1, 2024 - Podcast Online CME Education

Ashton C. Praska, PharmD describes tetracycline resistance mechanisms utilized by bacteria, identifies how Omadacycline/Eravacycline can overcome common tetracycline resistance mechanisms and identifies clinical scenarios where Omadacycline/Eravacycline could be considered for use.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 134 : Freezing Ethylene Glycol Toxicity

Available until September 1, 2024 - Podcast Online CME Education

Kamryn R. Storm, PharmD outlines the mechanism of toxicity for ethylene glycol, identifies clinical findings of ethylene glycol toxicity and selects treatment regimens for suspected ethylene glycol toxicity.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 135 : A Hard-Pressed Debate: The Role of Terlipressin in Hepatorenal Syndrome

Available until September 1, 2024 - Podcast Online CME Education

Nikitha Yagnala, PharmD and Andy J. Jatis, PharmD, BCPS describe the pathophysiology of hepatorenal syndrome (HRS), describe the pathophysiology of hepatorenal syndrome (HRS) and outline an optimal patient care plan for the management of HRS.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 136 : Verification Decision Support: May AI Take Your Order?

Available until September 1, 2024 - Podcast Online CME Education

Benjamin J. Anderson, PharmD, MPH, FASHP and Diana J. Schreier, PharmD, MBA, BCPS recognize the history and regulations for prospective medication order review, describe the technical landscape for verification decision support and explore real-world verification decision support outcomes.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 137 : Measuring Value in Drug Therapy

Available until September 1, 2024 - Podcast Online CME Education

Benjamin J. Anderson, PharmD, MPH, FASHP and Diana J. Schreier, PharmD, MBA, BCPS recognize the history and regulations for prospective medication order review, describe the technical landscape for verification decision support and explore real-world verification decision support outcomes.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 138 : All-In on Insulin? Use of High-Dose Insulin Euglycemic Therapy in Calcium Channel Blocker Overdose

Available until September 1, 2024 - Podcast Online CME Education

Benjamin J. Anderson, PharmD, MPH, FASHP and Diana J. Schreier, PharmD, MBA, BCPS recognize the history and regulations for prospective medication order review, describe the technical landscape for verification decision support and explore real-world verification decision support outcomes.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 139 : On Another Level: The Role of Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Available until September 1, 2024 - Podcast Online CME Education

Sarah A. Chase, PharmD reviews the pathophysiology and current treatment strategies for inflammatory bowel disease, defines the clinical application of therapeutic drug monitoring of biologic therapies used in inflammatory bowel disease and discusses biologic therapy optimization based on therapeutic drug monitoring.

Enduring
    • 0.50 AMA PRA Category 1 Credit
    • 0.50 AAPA Category 1
    • 0.50 ACPE
    • 0.50 ANCC
    • 0.50 Attendance
Ongoing
Pharmacy Podcast Episode 140 : Updates on the Clozapine REMS Program: An Important Relic or Fool’s Gold of Safety?

Available until September 1, 2024 - Podcast Online CME Education

Jonathan Leung, PharmD, BCPS, BCPP provides updates on the clozapine REMS program, reviews the therapeutic benefits of clozapine, as well as key adverse events.

Enduring
    • 0.75 AMA PRA Category 1 Credit
    • 0.75 AAPA Category 1
    • 0.75 ACPE
    • 0.75 ANCC
    • 0.75 Attendance
Ongoing

Pages